Exchange: NASDAQ·Updated 04:00 PM EDT
LSTA logo

LSTA Lisata Therapeutics Inc

$1.64
$0.07
(4.46%)
Today
EarningsNov 5
Mkt Cap$14.78M
Vol162,868.00

About LSTA

Lisata Therapeutics, Inc. is a clinical-stage pharmaceutical company, which engages in the discovery, development, and commercialization of innovative therapies for the treatment of solid tumors and other major diseases. Its product, Certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered anti-cancer drugs to target and penetrate tumors. The company was founded in 1980 and is headquartered in Basking Ridge, NJ.
40

Bearish Sentiment

How do you feel about LSTA?

Advertisement|Remove ads.